Last 12 months
Inside the activity.
0 purchase rows · 64 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 26 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 10 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 05, 2024 Filed Feb 7, 2024 22:43 UTC |
Surdykowski Andrew JGeneral Counsel
|
Tax withholdingCommon Stock | 1,493 | $126.75 | $189,237.75 |
DisclosureSEC source: 0000950170-24-012348 · ownership.xml · nonDerivative · entry 2 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,612 F3 · shares: Represents shares of common stock underlying vested TSR PSUs that are being withheld to satisfy payment of the Issuer's tax withholding obligations. F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 40,712 shares of common stock and 4,900 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2025 and February 2026, respectively, and will be reported at the time of vesting. F5 · balance_after: The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 22:43 UTC |
Surdykowski Andrew JGeneral Counsel
|
GrantCommon Stock | 3,502 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-012348 · ownership.xml · nonDerivative · entry 1 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,105 F1 · shares: Represents shares issued to the filing person in connection with the vesting of the three-year total shareholder return performance based restricted stock units ("TSR PSUs") granted on February 5, 2021. The payout amount for the TSR PSUs was determined based on the Issuer's stock price through December 31, 2023 and was based on the total shareholder return from January 1, 2021 through December 31, 2023 relative to the S&P 500. F2 · balance_after: Amount of securities beneficially owned includes 110 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on December 29, 2023. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 22:40 UTC |
Martin Lynn CPresident, NYSE Group
|
Tax withholdingCommon Stock | 3,934 | $126.75 | $498,634.50 |
DisclosureSEC source: 0000950170-24-012342 · ownership.xml · nonDerivative · entry 2 Martin Lynn C · CIK 0001754817 · President, NYSE Group 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,288 F3 · shares: Represents shares of common stock underlying vested TSR PSUs that are being withheld to satisfy payment of the Issuer's tax withholding obligations. F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 42,273 shares of common stock, 1,280 unvested restricted stock units ("RSUs") and 9,735 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2025 and February 2026, respectively, and will be reported at the time of vesting. F5 · balance_after: The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 22:40 UTC |
Martin Lynn CPresident, NYSE Group
|
GrantCommon Stock | 7,706 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-012342 · ownership.xml · nonDerivative · entry 1 Martin Lynn C · CIK 0001754817 · President, NYSE Group 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,222 F1 · shares: Represents shares issued to the filing person in connection with the vesting of the three-year total shareholder return performance based restricted stock units ("TSR PSUs") granted on February 5, 2021. The payout amount for the TSR PSUs was determined based on the Issuer's stock price through December 31, 2023 and was based on the total shareholder return from January 1, 2021 through December 31, 2023 relative to the S&P 500. F2 · balance_after: Amount of securities beneficially owned includes 110 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on December 29, 2023. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 22:38 UTC |
Kapani MayurChief Technology Officer
|
Tax withholdingCommon Stock | 2,202 | $126.75 | $279,103.50 |
DisclosureSEC source: 0000950170-24-012336 · ownership.xml · nonDerivative · entry 2 Kapani Mayur · CIK 0001917418 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,747 F4 · shares: Represents shares of common stock underlying vested TSR PSUs that are being withheld to satisfy payment of the Issuer's tax withholding obligations. F5 · balance_after: The common stock number referred in Table I is an aggregate number and represents 50,076 shares of common stock and 6,671 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2025 and February 2026, respectively, and will be reported at the time of vesting. F6 · balance_after: The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 22:38 UTC |
Kapani MayurChief Technology Officer
|
GrantCommon Stock | 4,904 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-012336 · ownership.xml · nonDerivative · entry 1 Kapani Mayur · CIK 0001917418 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,949 F1 · shares: Represents shares issued to the filing person in connection with the vesting of the three-year total shareholder return performance based restricted stock units ("TSR PSUs") granted on February 5, 2021. The payout amount for the TSR PSUs was determined based on the Issuer's stock price through December 31, 2023 and was based on the total shareholder return from January 1, 2021 through December 31, 2023 relative to the S&P 500. F2 · balance_after: Amount of securities beneficially owned includes 109 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2023. F3 · balance_after: Amount of securities beneficially owned includes 100 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on December 29, 2023. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 22:37 UTC |
Jackson BenjaminPresident
|
Tax withholdingCommon Stock | 4,745 | $126.75 | $601,428.75 |
DisclosureSEC source: 0000950170-24-012334 · ownership.xml · nonDerivative · entry 2 Jackson Benjamin · CIK 0001722067 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,617 F3 · shares: Represents shares of common stock underlying vested TSR PSUs that are being withheld to satisfy payment of the Issuer's tax withholding obligations. F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 120,343 shares of common stock and 13,274 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2025 and February 2026, respectively, and will be reported at the time of vesting. F5 · balance_after: The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 22:37 UTC |
Jackson BenjaminPresident
|
GrantCommon Stock | 10,508 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-012334 · ownership.xml · nonDerivative · entry 1 Jackson Benjamin · CIK 0001722067 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,362 F1 · shares: Represents shares issued to the filing person in connection with the vesting of the three-year total shareholder return performance based restricted stock units ("TSR PSUs") granted on February 5, 2021. The payout amount for the TSR PSUs was determined based on the Issuer's stock price through December 31, 2023 and was based on the total shareholder return from January 1, 2021 through December 31, 2023 relative to the S&P 500. F2 · balance_after: Amount of securities beneficially owned includes 110 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on December 29, 2023. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 22:35 UTC |
Foley DouglasSVP, HR & Administration
|
Tax withholdingCommon Stock | 630 | $126.75 | $79,852.50 |
DisclosureSEC source: 0000950170-24-012332 · ownership.xml · nonDerivative · entry 2 Foley Douglas · CIK 0001918894 · SVP, HR & Administration 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,383 F3 · shares: Represents shares of common stock underlying vested TSR PSUs that are being withheld to satisfy payment of the Issuer's tax withholding obligations. F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 15,728 shares of common stock and 2,655 unvested performance based restricted stock units, for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2025 and February 2026, respectively, and will be reported at the time of vesting. F5 · balance_after: The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 22:35 UTC |
Foley DouglasSVP, HR & Administration
|
GrantCommon Stock | 2,101 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-012332 · ownership.xml · nonDerivative · entry 1 Foley Douglas · CIK 0001918894 · SVP, HR & Administration 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,013 F1 · shares: Represents shares issued to the filing person in connection with the vesting of the three-year total shareholder return performance based restricted stock units ("TSR PSUs") granted on February 5, 2021. The payout amount for the TSR PSUs was determined based on the Issuer's stock price through December 31, 2023 and was based on the total shareholder return from January 1, 2021 through December 31, 2023 relative to the S&P 500. F2 · balance_after: Amount of securities beneficially owned includes 110 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on December 29, 2023. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 22:34 UTC |
Edmonds Christopher ScottPresident, Fixed Income & Data
|
Tax withholdingCommon Stock | 1,595 | $126.75 | $202,166.25 |
DisclosureSEC source: 0000950170-24-012330 · ownership.xml · nonDerivative · entry 2 Edmonds Christopher Scott · CIK 0001919795 · President, Fixed Income & Data 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,550 F3 · shares: Represents shares of common stock underlying vested TSR PSUs that are being withheld to satisfy payment of the Issuer's tax withholding obligations. F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 6,138 shares of common stock and 2,035 unvested restricted stock units ("RSUs"), and 5,377 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2025 and February 2026, respectively, and will be reported at the time of vesting. F5 · balance_after: The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 22:34 UTC |
Edmonds Christopher ScottPresident, Fixed Income & Data
|
GrantCommon Stock | 3,502 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-012330 · ownership.xml · nonDerivative · entry 1 Edmonds Christopher Scott · CIK 0001919795 · President, Fixed Income & Data 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,145 F1 · shares: Represents shares issued to the filing person in connection with the vesting of the three-year total shareholder return performance based restricted stock units ("TSR PSUs") granted on February 5, 2021. The payout amount for the TSR PSUs was determined based on the Issuer's stock price through December 31, 2023 and was based on the total shareholder return from January 1, 2021 through December 31, 2023 relative to the S&P 500. F2 · balance_after: Amount of securities beneficially owned includes 110 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on December 29, 2023. Read SEC document |
| January 25, 2024 Filed Jan 26, 2024 22:41 UTC |
Gardiner WarrenChief Financial Officer
|
GiftCommon Stock | 590 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-002309 · doc4.xml · nonDerivative · entry 1 Gardiner Warren · CIK 0001855007 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,435 F1 · shares: This transaction involved a gift of 590 shares of the issuer's common stock by the reporting person to a philanthropic organization. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 8,870 shares of common stock and 1,345 unvested restricted stock units ("RSUs"), and 4,220 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2025 and February 2026, respectively, and will be reported at the time of vesting. F3 · balance_after: The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. Read SEC document |
| January 04, 2024 Filed Jan 5, 2024 17:43 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 58,388 | $0.00 Strike: $50.01 | $0.00 |
DisclosureSEC source: 0001209191-24-001057 · doc4.xml · derivative · entry 9 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 116,777 Underlying: Common Stock · 58,388 shares Expires 2026-01-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_date: These options are fully vested. Read SEC document |
| January 04, 2024 Filed Jan 5, 2024 17:43 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 12,581 | $126.41 | $1,590,302.56 |
DisclosureSEC source: 0001209191-24-001057 · doc4.xml · nonDerivative · entry 7 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · CPEX Disclosed balance after: 2,771,705 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of August 7, 2023. F10 · price: The price range for the aggregate amount sold by the direct holder is $126.34 - $126.50. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F11 · balance_after: As previously reported, the reporting person also indirectly owns 2,771,705 shares that are beneficially owned directly by CPEX. The reporting person beneficially owns 100% of the equity interest in CPEX. Additionally, as previously reported, the reporting person indirectly owns shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership. Read SEC document |
| January 04, 2024 Filed Jan 5, 2024 17:43 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 82,150 | $125.99 | $10,350,021.00 |
DisclosureSEC source: 0001209191-24-001057 · doc4.xml · nonDerivative · entry 6 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · CPEX Disclosed balance after: 2,784,286 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of August 7, 2023. F9 · price: The price range for the aggregate amount sold by the direct holder is $125.34 - $126.33. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| January 04, 2024 Filed Jan 5, 2024 17:43 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 15,269 | $125.02 | $1,908,899.84 |
DisclosureSEC source: 0001209191-24-001057 · doc4.xml · nonDerivative · entry 5 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · CPEX Disclosed balance after: 2,866,436 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of August 7, 2023. F8 · price: The price range for the aggregate amount sold by the direct holder is $124.34 - $125.33. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| January 04, 2024 Filed Jan 5, 2024 17:43 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 3,200 | $126.44 | $404,608.96 |
DisclosureSEC source: 0001209191-24-001057 · doc4.xml · nonDerivative · entry 4 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,152,375 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of August 7, 2023. F5 · price: The price range for the aggregate amount sold by the direct holder is $126.41 - $126.50. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F6 · balance_after: The common stock number referred in Table I is an aggregate number and represents 1,110,990 shares of common stock and 41,385 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2021, 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024, February 2025 and February 2026, respectively, and will be reported at the time of vesting. F7 · balance_after: The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. Read SEC document |
| January 04, 2024 Filed Jan 5, 2024 17:43 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 46,787 | $126.02 | $5,896,228.74 |
DisclosureSEC source: 0001209191-24-001057 · doc4.xml · nonDerivative · entry 3 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,155,575 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of August 7, 2023. F4 · price: The price range for the aggregate amount sold by the direct holder is $125.41 - $126.40. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| January 04, 2024 Filed Jan 5, 2024 17:43 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
SaleCommon Stock | 8,401 | $125.03 | $1,050,353.51 |
DisclosureSEC source: 0001209191-24-001057 · doc4.xml · nonDerivative · entry 2 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,202,362 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of August 7, 2023. F3 · price: The price range for the aggregate amount sold by the direct holder is $124.41 - $125.39. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| January 04, 2024 Filed Jan 5, 2024 17:43 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 58,388 | $50.01 | $2,919,983.88 |
DisclosureSEC source: 0001209191-24-001057 · doc4.xml · nonDerivative · entry 1 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,210,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of August 7, 2023. F2 · balance_after: Amount of securities beneficially owned includes 110 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on December 29, 2023. Read SEC document |
| December 29, 2023 Filed Jan 2, 2024 21:35 UTC |
Jackson BenjaminPresident
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 2,560 | $0.00 Strike: $41.59 | $0.00 |
DisclosureSEC source: 0001209191-24-000133 · doc4.xml · derivative · entry 2 Jackson Benjamin · CIK 0001722067 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,970 Underlying: Common Stock · 2,560 shares Expires 2025-01-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options are fully vested. Read SEC document |
| December 29, 2023 Filed Jan 2, 2024 21:35 UTC |
Jackson BenjaminPresident
|
Exercise / conversionCommon Stock | 2,560 | $41.59 | $106,470.40 |
DisclosureSEC source: 0001209191-24-000133 · doc4.xml · nonDerivative · entry 1 Jackson Benjamin · CIK 0001722067 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,744 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The common stock number referred in Table I is an aggregate number and represents 114,470 shares of common stock and 13,274 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2021, 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024, February 2025 and February 2026, respectively, and will be reported at the time of vesting. F2 · balance_after: The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. Read SEC document |
| December 26, 2023 Filed Dec 28, 2023 21:23 UTC |
Surdykowski Andrew JGeneral Counsel
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 1,000 | $0.00 Strike: $57.31 | $0.00 |
DisclosureSEC source: 0001209191-23-059902 · doc4.xml · derivative · entry 7 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,439 Underlying: Common Stock · 1,000 shares Expires 2027-01-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested. Read SEC document |
| December 26, 2023 Filed Dec 28, 2023 21:23 UTC |
Surdykowski Andrew JGeneral Counsel
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 500 | $0.00 Strike: $50.01 | $0.00 |
DisclosureSEC source: 0001209191-23-059902 · doc4.xml · derivative · entry 6 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,080 Underlying: Common Stock · 500 shares Expires 2026-01-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested. Read SEC document |
| December 26, 2023 Filed Dec 28, 2023 21:23 UTC |
Surdykowski Andrew JGeneral Counsel
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 500 | $0.00 Strike: $41.59 | $0.00 |
DisclosureSEC source: 0001209191-23-059902 · doc4.xml · derivative · entry 5 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 500 shares Expires 2025-01-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested. Read SEC document |
| December 26, 2023 Filed Dec 28, 2023 21:23 UTC |
Surdykowski Andrew JGeneral Counsel
|
SaleCommon Stock | 2,364 | $126.00 | $297,864.00 |
DisclosureSEC source: 0001209191-23-059902 · doc4.xml · nonDerivative · entry 4 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,493 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 8, 2022. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 38,593 shares of common stock and 4,900 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2021, 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024, February 2025 and February 2026, respectively, and will be reported at the time of vesting. F3 · balance_after: The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. Read SEC document |
| December 26, 2023 Filed Dec 28, 2023 21:23 UTC |
Surdykowski Andrew JGeneral Counsel
|
Exercise / conversionCommon Stock | 1,000 | $57.31 | $57,310.00 |
DisclosureSEC source: 0001209191-23-059902 · doc4.xml · nonDerivative · entry 3 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 45,857 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 8, 2022. Read SEC document |
| December 26, 2023 Filed Dec 28, 2023 21:23 UTC |
Surdykowski Andrew JGeneral Counsel
|
Exercise / conversionCommon Stock | 500 | $50.01 | $25,005.00 |
DisclosureSEC source: 0001209191-23-059902 · doc4.xml · nonDerivative · entry 2 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,857 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 8, 2022. Read SEC document |
| December 26, 2023 Filed Dec 28, 2023 21:23 UTC |
Surdykowski Andrew JGeneral Counsel
|
Exercise / conversionCommon Stock | 500 | $41.59 | $20,795.00 |
DisclosureSEC source: 0001209191-23-059902 · doc4.xml · nonDerivative · entry 1 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,357 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 8, 2022. Read SEC document |
| December 14, 2023 Filed Dec 15, 2023 16:34 UTC |
Namkung James WChief Accounting Officer
|
SaleCommon Stock | 1,078 | $125.00 | $134,750.00 |
DisclosureSEC source: 0001209191-23-058782 · doc4.xml · nonDerivative · entry 2 Namkung James W · CIK 0001729468 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,599 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of March 9, 2023. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 14,179 shares of common stock and 438 unvested restricted stock units ("RSUs"), and 2,982 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2025 and February 2026, respectively, and will be reported at the time of vesting. F4 · balance_after: The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 16:34 UTC |
Namkung James WChief Accounting Officer
|
SaleCommon Stock | 1,171 | $120.00 | $140,520.00 |
DisclosureSEC source: 0001209191-23-058782 · doc4.xml · nonDerivative · entry 1 Namkung James W · CIK 0001729468 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,677 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of March 9, 2023. F2 · balance_after: Amount of securities beneficially owned includes 121 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2023. Read SEC document |
| December 11, 2023 Filed Dec 14, 2023 00:15 UTC |
Edmonds Christopher ScottChief Development Officer
|
SaleCommon Stock | 1,266 | $115.00 | $145,590.00 |
DisclosureSEC source: 0001209191-23-058557 · doc4.xml · nonDerivative · entry 1 Edmonds Christopher Scott · CIK 0001919795 · Chief Development Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,533 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of March 9, 2023. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 4,121 shares of common stock and 2,035 unvested restricted stock units ("RSUs"), and 5,377 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2021, 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024, February 2025 and February 2026, respectively, and will be reported at the time of vesting. F3 · balance_after: The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. Read SEC document |
| December 08, 2023 Filed Dec 11, 2023 21:36 UTC |
Gardiner WarrenChief Financial Officer
|
SaleCommon Stock | 500 | $112.34 | $56,170.00 |
DisclosureSEC source: 0001209191-23-058062 · doc4.xml · nonDerivative · entry 1 Gardiner Warren · CIK 0001855007 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,025 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of March 10, 2023. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 9,460 shares of common stock and 1,345 unvested restricted stock units ("RSUs"), and 4,220 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2025 and February 2026, respectively, and will be reported at the time of vesting. F3 · balance_after: The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. Read SEC document |
| December 07, 2023 Filed Dec 11, 2023 16:36 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
GiftCommon Stock | 17,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-058063 · doc4.xml · nonDerivative · entry 1 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,152,265 F1 · shares: This transaction involved a gift of 17,700 shares of the issuer's common stock by the reporting person to a philanthropic organization. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 1,110,880 shares of common stock and 41,385 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2021, 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024, February 2025 and February 2026, respectively, and will be reported at the time of vesting. F3 · balance_after: The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. Read SEC document |
| December 07, 2023 Filed Dec 11, 2023 21:37 UTC |
Surdykowski Andrew JGeneral Counsel
|
GiftCommon Stock | 225 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-058064 · doc4.xml · nonDerivative · entry 1 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,857 F1 · shares: This transaction involved a gift of 225 shares of the issuer's common stock by the reporting person to a philanthropic organization. F2 · balance_after: Amount of securities beneficially owned includes 121 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2023. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 38,957 shares of common stock and 4,900 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2021, 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024, February 2025 and February 2026, respectively, and will be reported at the time of vesting. F4 · balance_after: The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. Read SEC document |
| December 04, 2023 Filed Dec 6, 2023 21:38 UTC |
Martin Lynn CPresident, NYSE Group
|
Tax withholdingCommon Stock | 654 | $115.03 | $75,229.62 |
DisclosureSEC source: 0001209191-23-057613 · doc4.xml · nonDerivative · entry 1 Martin Lynn C · CIK 0001754817 · President, NYSE Group 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,406 F1 · shares: Represents shares of restricted stock issued to the filing person on December 3, 2021. The restricted stock units vest over three years (1/3 on December 3, 2022, 1/3 on December 3, 2023 and 1/3 on December 3, 2024). Of the 3,840 shares, 1,280 shares were issued on December 4, 2023, of which 654 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 1,280 shares are scheduled to be issued on December 3, 2024 and taxes for these issuances will be withheld and reported at the time of vesting. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 38,391 shares of common stock, 1,280 unvested restricted stock units ("RSUs") and 9,735 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2021, 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024, February 2025 and February 2026, respectively, and will be reported at the time of vesting. F3 · balance_after: The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. Read SEC document |
| December 04, 2023 Filed Dec 6, 2023 21:37 UTC |
Jackson BenjaminPresident
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 10,100 | $0.00 Strike: $41.37 | $0.00 |
DisclosureSEC source: 0001209191-23-057612 · doc4.xml · derivative · entry 4 Jackson Benjamin · CIK 0001722067 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,100 shares Expires 2024-01-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options are fully vested. Read SEC document |
| December 04, 2023 Filed Dec 6, 2023 21:37 UTC |
Jackson BenjaminPresident
|
SaleCommon Stock | 5,595 | $115.02 | $643,561.52 |
DisclosureSEC source: 0001209191-23-057612 · doc4.xml · nonDerivative · entry 3 Jackson Benjamin · CIK 0001722067 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 125,184 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of December 7, 2022. F3 · price: The price range for the aggregate amount sold by the direct holder is $114.91 - $115.18. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 111,910 shares of common stock and 13,274 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2021, 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024, February 2025 and February 2026, respectively, and will be reported at the time of vesting. F5 · balance_after: The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. Read SEC document |
| December 04, 2023 Filed Dec 6, 2023 21:37 UTC |
Jackson BenjaminPresident
|
SaleCommon Stock | 4,505 | $114.47 | $515,677.89 |
DisclosureSEC source: 0001209191-23-057612 · doc4.xml · nonDerivative · entry 2 Jackson Benjamin · CIK 0001722067 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 130,779 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of December 7, 2022. F2 · price: The price range for the aggregate amount sold by the direct holder is $113.91 - $114.89. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| December 04, 2023 Filed Dec 6, 2023 21:37 UTC |
Jackson BenjaminPresident
|
Exercise / conversionCommon Stock | 10,100 | $41.37 | $417,837.00 |
DisclosureSEC source: 0001209191-23-057612 · doc4.xml · nonDerivative · entry 1 Jackson Benjamin · CIK 0001722067 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 135,284 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of December 7, 2022. Read SEC document |
| December 04, 2023 Filed Dec 6, 2023 21:36 UTC |
Edmonds Christopher ScottChief Development Officer
|
SaleCommon Stock | 2,030 | $115.00 | $233,450.00 |
DisclosureSEC source: 0001209191-23-057610 · doc4.xml · nonDerivative · entry 1 Edmonds Christopher Scott · CIK 0001919795 · Chief Development Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,799 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of March 9, 2023. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 5,387 shares of common stock and 2,035 unvested restricted stock units ("RSUs"), and 5,377 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2021, 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024, February 2025 and February 2026, respectively, and will be reported at the time of vesting. F3 · balance_after: The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. Read SEC document |
| November 24, 2023 Filed Nov 28, 2023 21:38 UTC |
Foley DouglasSVP, HR & Administration
|
SaleCommon Stock | 1,600 | $114.46 | $183,136.00 |
DisclosureSEC source: 0001209191-23-056814 · doc4.xml · nonDerivative · entry 1 Foley Douglas · CIK 0001918894 · SVP, HR & Administration 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,802 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 23, 2022. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 14,147 shares of common stock and 2,655 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2021, 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024, February 2025 and February 2026, respectively, and will be reported at the time of vesting. F3 · balance_after: The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. Read SEC document |
| November 08, 2023 Filed Nov 9, 2023 21:32 UTC |
Jackson BenjaminPresident
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 5,000 | $0.00 Strike: $41.37 | $0.00 |
DisclosureSEC source: 0001209191-23-054843 · doc4.xml · derivative · entry 5 Jackson Benjamin · CIK 0001722067 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,100 Underlying: Common Stock · 5,000 shares Expires 2024-01-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: These options are fully vested. Read SEC document |
| November 08, 2023 Filed Nov 9, 2023 21:32 UTC |
Jackson BenjaminPresident
|
SaleCommon Stock | 1,370 | $109.18 | $149,576.05 |
DisclosureSEC source: 0001209191-23-054843 · doc4.xml · nonDerivative · entry 4 Jackson Benjamin · CIK 0001722067 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 125,184 F2 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of December 7, 2022. F4 · price: The price range for the aggregate amount sold by the direct holder is $109.10 - $109.25. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F5 · balance_after: The common stock number referred in Table I is an aggregate number and represents 111,910 shares of common stock and 13,274 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2021, 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024, February 2025 and February 2026, respectively, and will be reported at the time of vesting. F6 · balance_after: The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. Read SEC document |
| November 08, 2023 Filed Nov 9, 2023 21:32 UTC |
Jackson BenjaminPresident
|
SaleCommon Stock | 3,630 | $108.55 | $394,019.08 |
DisclosureSEC source: 0001209191-23-054843 · doc4.xml · nonDerivative · entry 3 Jackson Benjamin · CIK 0001722067 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 126,554 F2 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of December 7, 2022. F3 · price: The price range for the aggregate amount sold by the direct holder is $108.09 - $109.03. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| November 08, 2023 Filed Nov 9, 2023 21:32 UTC |
Jackson BenjaminPresident
|
Exercise / conversionCommon Stock | 5,000 | $41.37 | $206,850.00 |
DisclosureSEC source: 0001209191-23-054843 · doc4.xml · nonDerivative · entry 2 Jackson Benjamin · CIK 0001722067 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 130,184 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of December 7, 2022. Read SEC document |
| November 07, 2023 Filed Nov 9, 2023 21:35 UTC |
Martin Lynn CPresident, NYSE Group
|
GiftCommon Stock | 233 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-054845 · doc4.xml · nonDerivative · entry 1 Martin Lynn C · CIK 0001754817 · President, NYSE Group 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,060 F1 · shares: This transaction involved a gift of 233 shares of the issuer's common stock by the reporting person to a philanthropic organization. F2 · balance_after: Amount of securities beneficially owned includes 121 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2023. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 37,765 shares of common stock, 2,560 unvested restricted stock units ("RSUs") and 9,735 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2023 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024 and will be reported at the time of vesting. The satisfaction of the 2021, 2022 and 2023 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2024, February 2025 and February 2026, respectively, and will be reported at the time of vesting. F4 · balance_after: The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. Read SEC document |
| November 07, 2023 Filed Nov 9, 2023 21:32 UTC |
Jackson BenjaminPresident
|
GiftCommon Stock | 463 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-054843 · doc4.xml · nonDerivative · entry 1 Jackson Benjamin · CIK 0001722067 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 125,184 F1 · shares: This transaction involved a gift of 463 shares of the issuer's common stock by the reporting person to a philanthropic organization. Read SEC document |
| September 21, 2023 Filed Sep 25, 2023 16:43 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 70,442 | $0.00 Strike: $41.59 | $0.00 |
DisclosureSEC source: 0001209191-23-050484 · doc4.xml · derivative · entry 9 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 70,442 shares Expires 2025-01-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: These options are fully vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.